Skip to main navigation Skip to search Skip to main content

Spontaneous Pneumomediastinum, Pneumothorax and Subcutaneous Emphysema in COVID-19 Pneumonia: A Rare Case and Literature Review

  • Tarig Elhakim
  • , Haleem S. Abdul
  • , Yoandy Rodriguez-Fuentes
  • , Carlos A Pelaez Romero
    • HCA Healthcare

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Spontaneous pneumomediastinum (SPM) and pneumothorax (PNX) unrelated to positive pressure ventilation has been recently reported as an unusual complication in cases of severe COVID-19 pneumonia. The presumed pathophysiological mechanism is diffuse alveolar injury leading to alveolar rupture and air leak. We present a case of COVID-19 pneumonia complicated on day 13 post admission by SPM, PNX and subcutaneous emphysema in a patient with no identifiable risk factors for such complication. The patient received medical treatment for his COVID-19 infection without the use of an invasive or non-invasive ventilator. Moreover, he is a non-smoker with no lung comorbidities and never reported a cough. He was eventually discharged home in stable condition. A comprehensive literature review revealed 15 cases of SPM developing in patients with COVID-19 pneumonia.

    Original languageAmerican English
    JournalInfectious Disease
    StatePublished - Dec 12 2020

    Keywords

    • sars-cov-2
    • coronavirus infections
    • COVID-19

    Disciplines

    • Critical Care
    • Infectious Disease
    • Internal Medicine
    • Respiratory Tract Diseases
    • Virus Diseases

    Cite this